Bagmane Prime Office REIT IPO Subscription Status

Mainboard
Minimum investment
₹ 15,000 150 shares
View IPO details

Data sourced from BSE & NSE · Compiled by IPO Ji · IPO subscription data last updated

Total 24.96x·QIB 26.58x·NII 23.02x·Retail 0.00x

Bagmane Prime Office REIT Mainboard IPO was subscribed 24.96x in total when bidding closed on May 7, 2026, with 26.58x in the QIB category, 23.02x in NII, 0x in retail across BSE and NSE. This represents a strong oversubscription, reflecting heavy investor demand; a high subscription figure does not guarantee listing gains, and allotment follows the applicable category and exchange rules. The issue ran from May 5, 2026 to May 7, 2026 at a price band of ₹95–₹100 per share. Allotment was finalised on May 12, 2026.

QIB26.58xNII23.02xRetail0.00xTotal24.96x1x
Times subscribed by category against the 1× fully-subscribed line (bars capped at 10×).
Advertisement
Advertisement

Subscription Details (No. of Shares)

Category Offer Applied Times
QIBs 76649895 2037228750 26.58
Other Investors 63875055 1470509400 23.02
Total 140524950 3507738150 24.96

Subscription Details (In Crores)

Category Offered Demand Times
QIBs 766.5 20372.29 26.58
FIIs - 3255.14 -
DIIs - 4014.81 -
Mutual Funds - 1468.41 -
Others - 5047.58 -
Other Investors 638.75 14705.09 23.02
TOTAL 1405.25 35077.38 24.96

Day-wise subscription

Total subscription trend0.75x to 24.96x+24.21x
0.00x24.96x1x0.75xDay 12.35xDay 224.96xDay 3
As on QIB
NII
bHNI
sHNI
Retail Total
Day 1
5 May 2026
5:00 PM
0.73x
0.77x
0.00x
0.00x
0.00x 0.75x
Day 2
6 May 2026
5:00 PM
0.94x
4.03x
0.00x
0.00x
0.00x 2.35x
Day 3
7 May 2026
5:00 PM
26.58x
23.02x
0.00x
0.00x
0.00x 24.96x

Subscription by number of applications

Anticipated subscription based on the number of applications received (an alternative to the shares-based figures above), sourced from BSE & NSE.

CategoryTimes (by applications)
bHNI0.00x
sHNI0.00x
Retail0.00x
Total applications~2,01,140

What this means for allotment & listing

Because Bagmane Prime Office REIT closed oversubscribed, applicants were not guaranteed full allotment. In oversubscribed issues, shares are allotted according to the applicable category and exchange rules, so applicants are not guaranteed full allotment once an issue is oversubscribed. The number of times each category is subscribed is one indicator of demand, alongside the company's fundamentals and the broader market.

A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice. Investors should read the company's prospectus and consult a SEBI-registered adviser before making any decision.

Listed at BSE, NSE · Registrar: kfintech Technologies Ltd. · Bidding data sourced from the BSE & NSE public-issue platforms under SEBI ICDR regulations.

IPO subscription status shows how many times an issue has been applied for, compared with the shares on offer, broken down by Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), and the Retail or SME Individual Investor category. A figure of "2x" means investors applied for twice the shares available. See how IPO subscription works and track all live IPOs →

Bagmane Prime Office REIT IPO subscription FAQs

Bagmane Prime Office REIT IPO was subscribed 24.96x at close on May 7, 2026, with 26.58x in QIB, 23.02x in NII, 0x in retail.

Yes. Bagmane Prime Office REIT IPO was subscribed 24.96x, meaning investors applied for 24.96x the number of shares on offer.

The Bagmane Prime Office REIT IPO allotment was finalised on May 12, 2026. You can check your allotment status by PAN or application number on the registrar's website or on IPO Ji.

Bagmane Prime Office REIT IPO has a price band of ₹95–₹100 per share, with a minimum retail application of ₹15,000 for 150 shares.

It means investors have applied for X times the number of shares the company is offering. For example, 5x means demand was five times the shares available. A figure above 1x is called oversubscription; below 1x is undersubscription.

No. The higher an issue is oversubscribed, the lower each applicant’s chance of allotment. In oversubscribed retail categories, shares are allotted by a computerised lottery, so every valid applicant has an equal chance regardless of how many lots they applied for.

QIB (Qualified Institutional Buyers) are large institutions like banks, mutual funds and insurers. NII (Non-Institutional Investors) are high-net-worth individuals and bodies applying above ₹2 lakh. Retail individual investors apply up to ₹2 lakh. Each category has a reserved portion of the issue.

IPO Ji updates subscription figures through the bidding day using data sourced from BSE and NSE. The "Last updated" time shown on the page reflects the most recent refresh.

Other live IPO subscriptions

Advertisement
Important Disclaimer

Data Source: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites.

Purpose: The information / data provided herein is for informational purposes only and is provided by ipoji.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied.

Accuracy: ipoji.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites.

Liability: ipoji.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. ipoji.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites.

User Responsibility: The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.